USA FINANCIAL FORMULAS’s United Therapeutics UTHR Stock Holding History

USA FINANCIAL FORMULAS’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$235K	Buy	+434	New	+$244K	0.04%	117

Other funds holding UTHR

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

USA FINANCIAL FORMULAS's UTHR Position: Q2 2026 in Review

USA FINANCIAL FORMULAS opened a new position in United Therapeutics (UTHR) in Q2 2026: 434 shares worth $235K. The stake represents 0.04% of the portfolio and ranks #117 among its holdings.

330 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

USA FINANCIAL FORMULAS held 434 shares of United Therapeutics worth $235K as of Q2 2026.
United Therapeutics was a new USA FINANCIAL FORMULAS position in Q2 2026.
United Therapeutics made up 0.04% of USA FINANCIAL FORMULAS's portfolio in Q2 2026, its #117 holding.
330 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on USA FINANCIAL FORMULAS's 13F filing for Q2 2026, filed 4 Aug 2026.